胸部CT评估中西药联合治疗肺结核的临床价值研究

Research on evaluating the clinical value of the integrative medicine on tuberculosis by thoracic CT

目的:本次研究通过胸部CT征象变化探讨中西药联合治疗肺结核的临床价值。方法:选取2013年6月-2015年7月在我院接受治疗的肺结核患者96例,将其随机分为观察组和对照组,每组患者各48例。观察组采取2HR2E/4HR化疗方案联合中药进行治疗,对照组采取2HR2E/4HR化疗方案进行治疗。比较两组治疗方案的CT初始征象情况变化、治疗效果、病灶的吸收情况以及空洞的闭合情况。结果:对照组的总有效率为72.92%,观察组的总有效率为100.00%,并且观察组CT初始征象的改善情况、病灶的吸收、空洞的闭合等几项指标均优于对照组。经过统计学分析,P<0.05,差异具有统计学意义。结论:通过胸部CT对观察组和对照组进行比较分析,表明中西药联合治疗肺结核可有效抑菌、杀菌,提高治疗效率,改善患者的免疫力,应在临床上广泛应用。

Objective： To explore the clinical value of the integrative medicine on tuberculosis by the changes of thoracic CT signs. Methods： 96 cases of pulmonary tuberculosis treated in our hospital from June 2013 to July 2015 were randomly divided into the observation group and control group, 48 patients in each group. The observation group was treated by 2HR2E/4HR chemotherapy plus TCM medicines, and the control group was treated by 2HR2E/4HR chemotherapy. The changes of CT initial signs, treatment efects, the absorption of lesion and the closure of the cavities were compared between two groups. Results： The total efective rate in the control group was 72.92%, and in the observation group was 100.00%. Several indexes in the observation group were better than those in the control group, such as the improvement of CT initial signs, the absorption of lesions and the closure of cavities, with statistically signifcant diferences, P〈0.05. Conclusion： The comparison between the observation group and the control group by thoracic CT showed that the integrative medicine can efectively inhibit and sterilize bacteria, improve the efciency and immunity of patients, should be widely used in clinic.